Active	Status	Sponsor type	Region	Phase	Filter
23 Active 2 Inactive 25 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gupta, Pankaj
NCT04747236: Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL	Recruiting	2	50	US	Azacytidine, Vidaza, Romidepsin, Istodax, Belinostat, Beleodaq, Pralatrexate, Folotyn, Gemcitabine, Gemzar	University of Virginia, Celgene	PTCL	06/26	06/28
OUTREACH, NCT03293147: Urine Analysis and Antihypertensive Treatment	Completed	N/A	200	Europe	HPLC-MS/MS-guided intervention, Standard care	University of Manchester, British Heart Foundation, Manchester Academic Health Science Centre, Omron Healthcare Co., Ltd.	Hypertension, Adherence, Medication	08/23	09/23
Stage IV NSCLC, NCT06671613: Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer	Not yet recruiting	N/A	66	US	FMD, Xentigen, Regular Diet Plus FMD, Regular Diet Plus Xentigen	VA Office of Research and Development, Indiana University, US Department of Veterans Affairs Cooperative Studies Program, L-Nutra Inc	Stage IV NSCLC, NSCLC, Immunotherapy, Fasting Mimicking Diet	12/29	12/30
Raghupathy, Sangeetha
NCT05555589: Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2	Recruiting	3	70	US	RGN-259, Tβ4, Thymosin Beta 4, Timbetasin, Placebo, Vehicle Control	ReGenTree, LLC	Neurotrophic Keratopathy	07/24	11/24
Stephens, Barbara
No trials found
Hendershott, Lori
No trials found
Spruill, Rashad
No trials found